This report examines infectious disease preparedness across 10 indicators in each state of the US, in the context of Ebola and preparing for MERS-CoV and other emerging infectious diseases.
This report examines infectious disease preparedness across 10 indicators in each state of the US, particularly in reference to the recent Ebola outbreak.
This report examines the status of public health preparedness in the United States following the erosion caused by the financial crisis and ensuing budget cuts.
This report examines the progress since 2009 in terms of preparedness for public health emergencies and discusses the consequences of recent budget cuts at all levels of government.
This report examines the progress that the government has made in its ability to respond to public health emergencies since 2003 and evaluates the United States response to H1N1 .
This report examines the progress that the government has made in its ability to respond to public health emergencies since 2003, with consideration to the fact it is a political transition year.
This is the fourth report in the series that seeks to assess the level of preparedness in the states, evaluate the federal government�s role and performance, and offer recommendations for improving emergency preparedness in case of a biological…
This progress report details the progress of the National Institute of Allergy and Infectious Diseases towards the recommendations made by the Blue Ribbon Panel on Bioterrorism and Its Implications for Biomedical Research in February 2002. These…
This hearing before the Committee on Foreign Relations held two panels to discuss the threat of biological weapons use and emerging infectious diseases, calling on experts in both fields. The first panel was centered on a smallpox simulation known as…
In the wake of the 9/11 terrorist attacks, the Subcommittee of the Committee on Appropriations discusses US preparedness for a bioterrorism event in a series of hearings over a few weeks.
This report aims to make recommendations to medical and public health professionals for measures to be taken following the use of smallpox as a biological weapon against a civilian population.
This hearing before the Subcommittee on Public Health examines topics related to US bioterrorism preparedness, such as the national pharmaceutical stockpile, deterrence, outbreak containment, and research and development.
This paper evaluates African horse sickness, Lumpy skin disease, Pernospora hyoscyami, and Claviceps purpurea on the lists of animal pathogens and plant pathogens